BIOCOMPATIBILITY OF EXTRACORPOREAL CIRCUITS IN HEART-SURGERY

[41] Cochrane, Griffin, The biochemistry and pathophysiology of the contact system of plasma, Adv Immunol, 33, pp. 241-294, (1982)

[42] Rosenberg, Damus, The purification and mechanism of action of human antithrombin-heparin cofactor, J Biol Chem, 248, pp. 6490-6505, (1973)

[43] Heimark, Kurachi, Fujikawa, Davie, Surface activation of blood coagulation, fibrinolysis and kinin formation, Nature (London), 286, pp. 456-460, (1980)

[44] Davies, Sobel, Salzman, Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass, Circulation, 61, pp. 808-814, (1980)

[45] Mammen, Koets, Washington, Wolk, Brown, Burdick, Selik, Wilson, Hemostasis changes during cardiopulmonary surgery, Semin Thromb Hemostas, 11, pp. 281-292, (1985)

[46] Stibbe, Kluft, Brommer, Gomes, de Jong, Nauta, Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator, Eur J Clin Invest, 14, pp. 375-382, (1984)

[47] Belitser, Lugovskoy, Musjalkovskaja, Gogolinskaja, Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization, Thromb Res, 27, pp. 261-269, (1982)

[48] Niewiarowski, Budzynski, Morinelli, Brudzynski, Stewart, Exposure of fibrinogen receptor on human platelets by proteolytic enzymes, J Biol Chem, 256, pp. 917-925, (1981)

[49] Dang, Bell, Kaiser, Wong, Disorganization of cultured vascular endothelial cell monolayers by fibringen fragment D, Science, 227, pp. 1487-1490, (1985)

[50] Ward, A plasmin-split fragment of C′3 as a new chemotactic factor, J Exp Med, 126, pp. 189-206, (1967)

[41] Cochrane, Griffin, The biochemistry and pathophysiology of the contact system of plasma, Adv Immunol, 33, pp. 241-294, (1982)

[42] Rosenberg, Damus, The purification and mechanism of action of human antithrombin-heparin cofactor, J Biol Chem, 248, pp. 6490-6505, (1973)

[43] Heimark, Kurachi, Fujikawa, Davie, Surface activation of blood coagulation, fibrinolysis and kinin formation, Nature (London), 286, pp. 456-460, (1980)

[44] Davies, Sobel, Salzman, Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass, Circulation, 61, pp. 808-814, (1980)

[45] Mammen, Koets, Washington, Wolk, Brown, Burdick, Selik, Wilson, Hemostasis changes during cardiopulmonary surgery, Semin Thromb Hemostas, 11, pp. 281-292, (1985)

[46] Stibbe, Kluft, Brommer, Gomes, de Jong, Nauta, Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator, Eur J Clin Invest, 14, pp. 375-382, (1984)

[47] Belitser, Lugovskoy, Musjalkovskaja, Gogolinskaja, Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization, Thromb Res, 27, pp. 261-269, (1982)

[48] Niewiarowski, Budzynski, Morinelli, Brudzynski, Stewart, Exposure of fibrinogen receptor on human platelets by proteolytic enzymes, J Biol Chem, 256, pp. 917-925, (1981)

[49] Dang, Bell, Kaiser, Wong, Disorganization of cultured vascular endothelial cell monolayers by fibringen fragment D, Science, 227, pp. 1487-1490, (1985)

[50] Ward, A plasmin-split fragment of C′3 as a new chemotactic factor, J Exp Med, 126, pp. 189-206, (1967)